R&SP Home

Calendars
November
December

Archive

FAQs

Subscribe or Unsubscribe

R&SP Holiday Closing Information

Thanksgiving
The IUPUI Research and Sponsored Programs (R&SP) office will close at 2:00 P.M. on Wednesday, November 21, 2001 and reopen Monday, November 26, 2001 with regular business hours from 8:00 A.M. to 5:00 P.M.

Christmas/New Year's
Research Compliance Administration (IRB/IBC)
The office of Research and Sponsored Programs (UN 618) will be closed December 24, 2001 through January 1, 2002. We will reopen January 2, 2002 at 8:00 A.M. If there is a life-threatening emergency which necessitates the use of an investigational agent, please call University Hospital Pharmacy at 274-0362.
Sponsored Program Administration
The office of Research and Sponsored Programs (UN 618) will be closed December 24, 2001 through January 1, 2002. We will reopen January 2, 2002 at 8:00 A.M. Proposals with a postmark or receipt date of January 2 or earlier must be received by R&SP no later than December 19, 2001. Proposals with a postmark or receipt date of January 3 or 4 must be received no later than December 21, 2001. Proposals will not be processed during the holiday period.
Sponsored Program Development
The office of Research and Sponsored Programs (UL 1140) will be closed December 17, 2001 through January 1, 2002. We will reopen January 2, 2002 at 8:00 A.M.

The staff of R&SP wishes everyone a happy, peaceful, and safe Holiday Season!

NIH Policy on Reporting Race and Ethnicity Data: Human Subjects in Clinical Research
The National Institutes of Health (NIH) has adopted the 1997 Office of Management and Budget (OMB) revised minimum standards for maintaining, collecting, and presenting data on race and ethnicity. This policy applies to all new applications and proposals, annual progress reports, competing continuation applications, competing supplement applications for research grants, contracts, and intramural projects as of January 10, 2002.
Complete Details

Important Reminder from the IUPUI IBC
Investigators are reminded by the IUPUI Institutional Biosafety Committee (IBC) that even though an investigator may have an approved study at a certain risk level, e.g. BL2, BL1, etc., this DOES NOT give the investigator blanket approval for any other work/experiments with other vectors or agents at that same level. New vectors and/or agents require either an amendment or a new study submission.

Using Updated Forms Prevents Delays
The IUPUI Research and Sponsored Programs (R&SP) office reminds all investigators to verify that they are using the most recent version of an agency form prior to submitting the form to R&SP. Agencies frequently update forms to reflect new policies and requirements. Outdated forms will be returned to the investigator for correction and may result in unnecessary delays. Investigators should access the R&SP Web site at http://www.iupui.edu/~resgrad/spon/formscontent.htm for updated forms each time new forms are submitted to R&SP. Please share this information with faculty and administrators in your school and emphasize the importance of using the correct form to avoid delays.

Compliance Training Required for Shipping Infectious and Diagnostic Substances
IUPUI/Clarian staff must be trained in the proper handling and shipping of potentially dangerous goods. This includes those who may ship to centralized labs or other research facilities. The label "dangerous goods" may apply to blood, urine or other body tissue. Training includes, in part, learning to differentiate between "dangerous" and non-dangerous goods.
Complete Details

NIH Revises Policy for Requests of $500, 000 or More in Direct Costs
The National Institutes of Health (NIH) announced a revised policy on the acceptance for review of unsolicited applications that request $500,000 or more in direct costs. Effective with the January 1, 2002 receipt dates, applicants must seek agreement to accept assignment from Institute/Center staff at least 6 weeks prior to the anticipated submission of any application requesting $500,000 or more in direct costs for any year.
Complete Details

IUPUI IBC Guidelines for TAT Protein Use
The IUPUI Institutional Biosafety Committee (IBC) has become aware of investigators either wanting to initiate or purchase Trans-Activating Transduction (TAT) proteins or other tags, which promote protein entry into cells. Many investigators initially view TAT fusion protein expression vectors as just one of the many plasmids which they may use in their laboratory and as such, submission to the IBC may be an unexpected requirement. They may also view use of TAT fusion proteins outside the purview of the IBC. Expression of a TAT- fusion protein, even in bacteria, is considered rDNA work and falls under the auspice of the IBC particularly since the TAT protein has potentially distinctive and unknown infectious qualities. As such, the use of the TAT protein is categorized as biosafety level 2 (BSL2).
See Complete Details for IUPUI IBC Minimum Guidelines for TAT Protein Use.

User-Friendly NIH Forms Now Available
In response to comments and suggestions from the research community on how the National Institutes of Health (NIH) can enhance the PHS 398 and PHS 2590 application forms to make them more user-friendly, NIH has made the forms available as Rich Text Format files as well as Portable Document Format files. Additional information concerning the revisions to the forms can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-002.html. The forms can be downloaded at http://grants.nih.gov/grants/forms.htm.

Openings for Research Compliance Coordinators
The IUPUI Research and Sponsored Programs (R&SP) office has openings for two Research Compliance Coordinator positions. Resumes should be submitted only to the IUPUI Human Resources Administration at http://www.hra.iupui.edu. See Complete Details to view the job descriptions for these positions.